Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference24 articles.
1. The efficacy and azidothymidine (AZT) in the treatment of participants with AIDS and AIDS-related complex: a double-blind, placebo-cont rolled trial;Fischl;N Engl J Med,1987
2. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex;Fischl;JAMA,1989
3. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Group of the National Institute of Allergy and Infectious Diseases;Volberding;N Engl J Med,1990
4. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group;Cooper;N Engl J Med,1993
5. A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV- infected adults with CD4 cell count of 500 or more per cubic millimetre. N;Volberding;Engl J Med,1995
Cited by 456 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Update on treatment as prevention of HIV illness, death, and transmission: sub-Saharan Africa HIV financing and progress towards the 95–95–95 target;Current Opinion in HIV and AIDS;2022-11
2. New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?;FEMS Microbiology Reviews;2022-09-20
3. Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort;Infectious Diseases and Therapy;2022-04-11
4. The best backbone for HIV prevention, treatment, and elimination: Emtricitabine+tenofovir;Antiviral Therapy;2022-04
5. Marine mollusc extracts—Potential source of SARS‐CoV‐2 antivirals;Reviews in Medical Virology;2021-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3